Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124089213 | 12408921 | 3 | F | 20160811 | 20160526 | 20160819 | EXP | US-PFIZER INC-2016270286 | PFIZER | EIKELENBOOM-SCHIEVELD, S.. THE RELEVANCE OF CYTOCHROME P450 POLYMORPHISM IN FORENSIC MEDICINE AND AKATHISIA-RELATED VIOLENCE AND SUICIDE. JOURNAL OF FORENSIC AND LEGAL MEDICINE. 2016;41:65-71 | 33.00 | YR | F | Y | 0.00000 | 20160819 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124089213 | 12408921 | 1 | PS | SERTRALINE HCL | SERTRALINE HYDROCHLORIDE | 1 | UNK | U | 19839 | ||||||||||
| 124089213 | 12408921 | 2 | I | SERTRALINE HCL | SERTRALINE HYDROCHLORIDE | 1 | U | 19839 | |||||||||||
| 124089213 | 12408921 | 3 | I | VENLAFAXINE HCL | VENLAFAXINE HYDROCHLORIDE | 1 | 150 MG, DAILY | Y | U | 20699 | 150 | MG | |||||||
| 124089213 | 12408921 | 4 | I | VENLAFAXINE HCL | VENLAFAXINE HYDROCHLORIDE | 1 | 75 MG, DAILY | Y | U | 20699 | 75 | MG | |||||||
| 124089213 | 12408921 | 5 | I | TEMAZEPAM. | TEMAZEPAM | 1 | UNK | Y | 0 | ||||||||||
| 124089213 | 12408921 | 6 | I | TEMAZEPAM. | TEMAZEPAM | 1 | Y | 0 | |||||||||||
| 124089213 | 12408921 | 7 | I | QUETIAPINE. | QUETIAPINE | 1 | UNK | Y | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124089213 | 12408921 | 1 | Anxiety |
| 124089213 | 12408921 | 2 | Depression |
| 124089213 | 12408921 | 5 | Anxiety |
| 124089213 | 12408921 | 6 | Depression |
| 124089213 | 12408921 | 7 | Insomnia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124089213 | 12408921 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124089213 | 12408921 | Abnormal behaviour | |
| 124089213 | 12408921 | Aggression | |
| 124089213 | 12408921 | Akathisia | |
| 124089213 | 12408921 | Drug ineffective | |
| 124089213 | 12408921 | Drug interaction | |
| 124089213 | 12408921 | Fatigue | |
| 124089213 | 12408921 | Homicide | |
| 124089213 | 12408921 | Mood swings | |
| 124089213 | 12408921 | Panic attack | |
| 124089213 | 12408921 | Physical assault | |
| 124089213 | 12408921 | Suicidal behaviour | |
| 124089213 | 12408921 | Thinking abnormal | |
| 124089213 | 12408921 | Toxicity to various agents | |
| 124089213 | 12408921 | Withdrawal syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |